Clinical Trial - Trial ChiCTR-IIR-17014234
Access comprehensive clinical trial information for ChiCTR-IIR-17014234 through Pure Global AI's free database. This Phase 4 trial is sponsored by The General Hospital of People's Liberation Army and is currently Not yet recruiting. The study focuses on Type 2 Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR-IIR-17014234
Phase 4
Not yet recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR-IIR-17014234
View on Chinese Clinical Trial Registry
Untitled Trial
A 26-week, multi-center, open-label, randomized, parallel-group study to evaluate the efficacy and safety of two treatment regimens in patients with type 2 diabetes after short-term intensive insulin therapy: basal insulin based treatment versus twice-daily premixed insulin
Study Focus
Sponsor & Location
The General Hospital of People's Liberation Army
Sanofi (Beijing) Pharmaceutical Co., Ltd.
China
Timeline & Enrollment
Phase 4
N/A
Mar 30, 2020
ICD-10 Classifications
Type 2 diabetes mellitus
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with multiple complications
Data Source
Chinese Clinical Trial Registry
ChiCTR-IIR-17014234
Non-Device Trial